فهرست مطالب abdoljalal marjani
-
ObjectiveMuscle atrophy due to immobility is a common complication of many diseases and a consequence of therapeutic processes. Immobility and inactivity have been shown to be associated with increased inflammation. The aim of this study was to investigate the therapeutic potential of Wild Bitter Melon (WBM) (Momordica charantia Linn) on muscle atrophy due to immobility in a mouse model.Materials and MethodsThis study was performed in two phases of atrophy and recovery on male BALB/c mice which were divided into 3 groups: control, immobilized, and experimental. The treatment period with WBM at a dose of 400 mg/kg daily by gavage was 17 days, including 7 days of being immobilized and 10 days of recovery. At the end of each phase, half of the mice from each group were examined regarding the four limb grip strength, and then histological and biochemical analyses were done.ResultsThe tissue level of malondialdehyde (MDA) oxidative stress index in the atrophy phase in the atrophy group (5.4567±0.522) nmol/g compared to the control group (3.455±0.065) nmol significantly (p 0.001) <) increased. Also, the tissue level of MDA in the WBM group (3.87±0.035) showed a significant decrease compared to the atrophy group (p<0.01). The strength percentage of four limbs in the mice of the treatment group (-23.46±2.45) was significantly higher than that of the atrophy group (-30.60±3.15) at the end of the atrophy phase.ConclusionThe results suggest that the use of WBM reduces the degree of inflammation, oxidative stress and muscle damage, as well as muscle atrophy, which may improve the muscle atrophy in mice.Keywords: Wild bitter melon, Atrophy, Inflammation, Oxidative stress}
-
Background
Investigation of anti-cancer agents with desirable selective toxicity is critical for cancer therapy. The use of natural adjuvants can be a promising option in reducing the toxicity of the anti-cancer agent. The aim of this study was to investigate the potential application of melatonin (MLT) as a natural adjuvant molecule along with doxorubicin (DOX) to induce cytotoxicity in osteosarcoma (OS) cells.
MethodsHuman OS cell lines included Saos-2, MG-63, and Human Bone Marrow Mesenchymal Stem Cells (hBM-MSCs) were treated with free DOX, free MLT, DOX-loaded NPs (DOX-NPs), MLT-loaded NPs (MLT-NPs), combination of DOX and MLT (DOX-MLT) and combination of DOX and MLT-loaded NPs (DOX-MLT-NPs) in separated cell culture. Cell proliferation of experiments were evaluated by MTT assay after 24 h. Total protein levels were determined by enzyme immunoassay ELISA.
ResultsHerein, we found the combination of MLT with DOX, especially formulated in nanoform, is resulted in a significant reduction in the protein levels of both X-linked Inhibitor of Apoptosis (XIAP) and Survivin (p<0.0001). Indeed, there was a significant decrease in the expression of XIAP and Survivin when MLT is combined with DOX compared to the individual treatments.
ConclusionOur findings indicated the synergism of the antitumor effect could be due to the down-regulation of XIAP and Survivin in the levels of protein.
Keywords: -Melatonin, Doxorubicin, Osteosarcoma, Combination therapy} -
زمینه و هدفبیماری های قلبی - عروقی و از کار افتادن قلب از مهم ترین بیماری هایی هستند که جوامع تکامل یافته را درگیر می کنند. سلول های بنیادی می توانند نقش مهمی در تیمار بیماری قلبی بازی کنند. یکی از شایع ترین ترکیبات مورد استفاده برای القا تمایز سلول های بنیادی به کاردیومیوسیت، 5-آزاسیتیدین است. محتوای محیط کشت سلولی بر مورفولوژی و کیفیت سلول های تمایز یافته موثر است. این مطالعه به منظور تعیین اثر گلوکز بر بهینه سازی پروتکل تمایز سلول های بنیادی مزانشیمی مشتق از مغز استخوان انسان به سلول های شبه کاردیومیوسیت انجام شد.روش بررسیدر این مطالعه تجربی سلول های بنیادی مزانشیمی در محیط تمایزی حاوی 5-آزاسیتیدین و دو غلظت از گلوکز (5 و 25 میلی مولار) طی 21 روز کشت داده شدند. در مرحله بعد RNA کل استخراج و cDNA سنتز شد. سرانجام q-PCR برای تعیین مارکرهای ویژه قلبی و تایید تمایز انجام گردید. تمایز سلول های بنیادی مزانشیمی به سلول های کاردیومیوسیت با استفاده از چهار مارکر قلبی Connexin43، -cardiac actinα، TroponinT و TroponinI به روش q-PCR اندازه گیری و تایید شدند.یافته هامیزان بیان مارکرهای قلبی Connexin43، -cardiac actinα، TroponinT و TroponinI در هر دو غلظت 5 و 25 میلی مولاری گلوکز طی تمایز سلول های بنیادی مزانشیمی مشتق از مغز استخوان انسان به کاردیومیوسیت متفاوت بود؛ اما این تفاوت از نظر آماری معنی دار نبود.نتیجه گیریدو غلظت 5 و 25 میلی مولاری گلوکز اثر قابل ملاحظه ای بر بیان مارکرهای قلبی Connexin43، -cardiac actinα، TroponinT و TroponinI طی تمایز سلول های بنیادی مزانشیمی مشتق از مغز استخوان انسان به کاردیومیوسیت نداشتند.کلید واژگان: کاردیومیوسیت, سلول های بنیادی مزانشیمی, گلوکز, 5-آزاسیتیدین, مارکرهای قلبی}Background and ObjectiveCardiovascular diseases and heart failure are major diseases in developed countries. Stem cells showed specific features to play an important role in heart disease treatment. One of the most common compounds has been used to induce differentiation of stem cells into cardiomyocyte is 5-Azacytidine. Medium contents of cell culture such as different glucose concentrations also influence on morphology and function of final differentiated cells. This study was done to evaluate the effect of glucose on improvement of BM-MSC differentiation into cardiomyocyte - like cells.MethodsIn this experimental study, effect of two different glucose concentrations (5 and 25mM) on the mesenchymal stem cells differentiation (MSCs) to cardiomyocytes during 21 days was evaluated. Bone marrow MSCs (BM MSCs) seeded in differentiation medium which treated with 5-aza and 5 & 25mM glucose concentrations. In next step, total RNA was extracted and cDNA synthesis was carried out. Finally, quantitative polymerase chain reaction (Q-PCR) was done to determine level of cardiac-specific markers during differentiation process including Connexin43, α-cardiac actin, TroponinT and TroponinI.ResultsLevel of cardiac-specific markers during differentiation of mesenchymal stem cells to cardiomyocyte including Connexin43, α-cardiac actin, TroponinT and TroponinI in 5 and 25 mM of glucose concentration was diferent, but this diference was not significant.ConclusionOur results showed that two concentrations of glucose (5, 25mM) have no remarkable effect on the expression of cardiac markers during differentiation of bone marrow mesenchymal stem cells to cardiomyocyte.Keywords: Cardiomyocyte, Mesenchymal stem cell, Glucose, 5-Azacytidine, Cardiac-specific markers}
-
زمینه و هدفدر پیش شرطی شدن ایسکمیک (ischemic preconditioning: IPC) قلب در دوره های کوتاه مدت دچار ایسکمی شده و لذا در صورت مواجهه با ایسکمی طولانی، قسمت اعظم ناحیه دچار ایسکمی از آسیب محافظت می گردد. این مطالعه به منظور تعیین اثر محافظتی لووتیروکسین با مکانیسم کاهش استرس اکسیداتیو در مدل پیش شرطی سازی ایسکمیک در قلب موش صحرایی انجام شد.روش بررسیاین مطالعه تجربی روی 30 سر موش صحرایی نر نژاد ویستار در در سه گروه 10 تایی انجام شد. در گروه ایسکمی پرفیوژن مجدد (IR) ، قلب حیوان در دستگاه لانگندورف قرار گرفت. در گروه IPC قبل از ایسکمی ماژور در معرض 4 دوره ایسکمی 5 دقیقه ای همراه با پرفیوژن مجدد قرار گرفت. در گروه دریافت کننده داخل صفاقی لووتیروکسین با دوز 25 میکروگرم به ازای هر 100 گرم وزن حیوان، قلب در معرض ایسکمی پرفیوژن مجدد قرار گرفت. حجم ناحیه اینفارکت و میزان مالون دی آلدئید در بافت قلب سنجیده شد.یافته هاحجم ناحیه آسیب دیده گروه IR 26.55 میلی متر مکعب، گروه IPC 11.11 میلی متر مکعب و گروه دریافت کننده لووتیروکسین 12.56 میلی متر مکعب تعیین شد. تزریق لووتیروکسین همانند IPC حجم ناحیه آسیب دیده را به طور معنی داری نسبت به گروه IR پایین آورد (P<0.05). میزان مالون دی آلدئید در گروه IR 1328، در گروه IPC 777 و در گروه دریافت کننده لووتیروکسین 762 تعیین شد و در گروه های IPC و دریافت کننده لووتیروکسین نسبت به گروه IR کاهش نشان داد (P<0.05).نتیجه گیریتزریق لووتیروکسین با ایجاد پیش شرطی سازی ایسکمیک سبب کاهش اثر سوء ایسکمی پرفیوژن مجدد در قلب موش صحرایی می گردد.کلید واژگان: قلب, ایسکمی, لووتیروکسین, پیش شرطی سازی ایسکمیک, استرس اکسیداتیو}Background And ObjectiveA brief and short duration episode of ischemia is recorded in ischemic preconditioning (IPC). This latter condition provides a status in which large region of heart is protected when prolonged ischemia occurred. Levothyroxine play a protective role in IPC induction, and simultaneously with stress oxidative. This study was conducted to determine the protective effect of levothyroxine with oxidative stress reduction mechanism in ischemic preconditioning model in rat heart.MethodsThis experimental study was performed on 30 male Wistar rats in three groups of 10, as follows. In the reperfusion ischaemia group (IR), the heart of the animal was placed in a Langendorff apparatus. In the ischemic preconditioning group (IPC), prior to major ischemia, was exposed to 4 periods of 5-minute ischemia with reperfusion. In the intraperitoneally administered group, levothyroxine at a dose of 25 microgram per 100 g of body weight, the heart was exposed to reperfusion ischemia. The area of infarct and the level of malondialdehyde in the heart tissue were measured.ResultsThe volume of Infarcted region in IR and IPC groups was 26.55 and 11.11 respectively. The same index for the Levothyroxine receiver was 12.56. Based on these findings it was demonstrated that Levothyroxine injection reduced the Infarcted region significantly similar with IPC (PConclusionInjection of levothyroxine with ischemic preconditioning reduced the effect of reperfusion maladaptive ischemia in rat heart.Keywords: Heart, Ischemia, Levothyroxine, Ischemic Preconditioning, Oxidative Stress}
-
The prevalence of metabolic syndrome is increasing worldwide. Several factors such as hyperglycemia are associated with risk of developing metabolic syndrome. Metabolic syndrome is a clinical tool for identification of subjects at risk of diseases such as type 2 diabetes mellitus, which could be a predictor of metabolic syndrome. There may be an association between diabetes, metabolic syndrome and cardiovascular morbidity and mortality. This study aimed to review the literature on diabetes, as a component of metabolic syndrome.Keywords: Metabolic syndrome, Diabetes, Diseases}
-
BackgroundUnder nutrition is a health problem in developing countries and the main aim of this study was determine of the nutritional status and some sociodemographic factors among rural under‑5‑year children in the North of Iran in 2013.MethodsThis was a descriptive, cross‑sectional study, which carried out on 2530 children (637 = Fars‑native, 1002 = Turkman and 891 = Sistani) from 21 villages in the North of Iran. Villages were chosen by random sampling among 118, and all of under‑five children were chosen by simple sampling. For all of cases, a questionnaire with contain questions on the socialdemographic condition was completed and anthropometric indexes were measured by a learned team. Anthropometric data were compared with those in Centers for Disease Control and Prevention reference population. SPSS 18.0 software was used for statistical data analysis and P value under 0.05 included significations.ResultsGenerally, under nutrition (Z‑score ≤ −2) was observed in 6.6%, 18.5% and 3.3% based on underweight, stunting and wasting, respectively and there were in boys more than girls and in Sistani more than other ethnic groups. Based on underweight and stunting, under nutrition was seen in Sistani more than other ethnic groups. Among three ethnic groups, stunting was significant both in boys (P = 0.013) and in girls (P = 0.004), but wasting was significant only in girls (P = 0.001). The estimated odds ratio (OR) with 95% confidence interval of under nutrition was obtained from logistic regression. Compared with good economic group, the OR was 1.831 in poor economic groups (P = 0.001). The risk of under nutrition in Sistanish ethnic group was 1.754 times more than Fars‑native group (P = 0.001).ConclusionsUnder nutrition is a health problem among under‑5‑year children in rural area in the North of Iran and stunting was seen in an alarming rate among them. Among ethnic groups, Sistanish children more than others were under nourished. Poor economic status is a risk factor for under nutrition in this area.Keywords: Children, Iran, nutrition, sociodemographic}
-
BackgroundHypovitaminosis D has been associated with a series of cardiovascular risk factors, such as hypertension, metabolic disorders, obesity, peripheral artery disease, coronary artery disease, myocardial infarction, heart failure and stroke.ObjectiveTo assess the effect of oral vitamin D3 on cardiovascular risk factors in post-menopausal women with vitamin D insufficiency.Materials And MethodsIn this parallel, randomized, placebo-controlled trial, 76 healthy post-menopausal women with vitamin D insufficiency (defined as a 25-[OH] D level <75 nmol/L) were randomly assigned to receive vitamin D3 2000 IU once daily (n = 38) or placebo (n = 38). The trial was undertaken in the different health centers in Gorgan, north of Iran. Lipid profile, fasting blood sugar (FBS) and blood pressure of the patients was assessed at the beginning of the study and 12 weeks after the trial. Data were entered into the computer using SPSS and analyzed by t-test.ResultsFBS, lipid profile and blood pressure were not significantly different between the groups after 12 weeks (P > 0.05). No participant discontinued treatment due to adverse events.ConclusionsVitamin D dietary supplementation is unlikely to reduce cardiovascular risk factors in post-menopausal women with vitamin D deficiency.Keywords: Post_menopause_lipids_vitamin D deficiency_blood pressure_Iran}
-
IntroductionFLT3 ITD and D835 mutations occur in high frequency in AML and to a lower rate in ALL patients with poor prognosis.MethodsITD and D835 mutations were studied in 100 diagnosed acute leukemia patients including 27 AML and 73 ALL with various FAB classifications by PCR and PCR-RFLP, respectively. Subsequently, PCR products of positive samples were confirmed by sequencing analyses.ResultsITD mutations occurred in 10% of all pediatric acute leukemia, including AML and ALL. 25.9% of AML patients harbor a mutation in the ITD in various subtypes. The frequency of ITD mutations was 4% in ALL. Various insertions of nucleotides in ITD were observed, similar to those described in the literature previously.ConclusionThese preliminary data suggest that flt3-ITD mutations may play an important role in leukemogenesis in a proportion of children, particularly in the case of AML.Keywords: Acute leukemia, Flt3, ITD, PCR, RFLP}
-
BackgroundThis study was undertaken to determine the prevalence of psychological stress among Isfahan medical sciences students.Materials And MethodsCross-sectional, questionnaire-based survey was carried out among the 387 medical sciences students (medicine, pharmacy, and dentistry) of Isfahan, Iran through census. In academic year 2010–2011, Kessler-10 questionnaire was given to the students a month before semester examinations. Scores ≥20 were considered as indicative of positive stress symptoms.ResultsThe overall prevalence of stress among medical sciences students was found to be about 76.1%. The prevalence of stress among medicine students was 22.7% mild, 23% moderate and 21.4% severe while 32.8% showed no stress. The prevalence of stress among pharmacy students was 22.22%, 22.22%, 26.19%, and 29.36% mild, moderate, and severe and no stress, respectively. The prevalence of stress among dentistry students was 25% mild, 27% moderate, and 10% severe while 37.5% showed no stress. The prevalence of stress was higher (70.6%) in pharmacy students when compared with medicine (66.1%) and dentistry (62.5%) students. The odds of student having stress is higher in dentistry students (OR: 1.44, P= 0.33), where as the odds are decreasing in pharmacy student (OR: 1.16, P= 0.66). There is no statistically significant association between gender, ages, and term and having stress symptoms.ConclusionsThe high level of stress necessitates interventions like social and psychological support to improve the student’s well-being. A prospective study is needed to study the association of psychological morbidity with sources of stress and coping strategies.Keywords: Isfahan, Kessler, medical sciences students, stress, student support}
-
زمینه و هدفبیماری دیابت ممکن است با عدم تعادل بین تاثیر دفاعی آنتی اکسیدان ها و افزایش تولید رادیکال های آزاد ارتباط داشته باشد. با توجه به تناقض یافته ها و تعیین تغییرات مالون دی آلدئید پلاسما و فعالیت آنزیم آنتی اکسیدان سوپراکسیددسموتاز گلبول قرمز در بیماران دیابتی نوع II مطالعه حاضر طراحی و انجام شد.روش کاراین مطالعه مورد- شاهدی با روش نمونه گیری تصادفی در سال 1384 انجام شد. 38 بیمار دیابتی نوع II مراجعه کننده به درمانگاه دیابت مرکز آموزشی- درمانی پنج آذر و 19 فرد سالم که از لحاظ سن و جنس با بیماران دیابتی همسان بودند برای مطالعه انتخاب گردیدند. از بیماران نمونه خون هپارینه تهیه شد. پلاسمای جدا شده جهت انجام آزمایش قند خون، پراکسیداسیون لیپید و گلبول های قرمز خون جهت آزمایش های هموگلوبین گلیکوزیله و فعالیت آنزیم سوپراکسید دسموتاز استفاده شد. در پایان نتایج به دست آمده با برنامه آماری SPSS نسخه 10 و آزمون تی مورد تجزیه و تحلیل قرار گرفت.یافته هادر مطالعه حاضر سطح پلاسمایی مالون دی آلدئید بیماران دیابتی نوع II (6/27±0/80 نانومول در میلی لیتر) در مقایسه با گروه کنترل (0/98± 3/56 نانومول در میلی لیتر) افزایش معنی داری نشان داد (p<0/05). فعالیت آنزیم سوپراکسید دسموتاز گلبول قرمز بیماران دیابتی نوع II (678/78 ±59/36) واحد در گرم هموگلوبین در مقایسه با گروه کنترل (52/98 ± 1056/47 واحد در گرم هموگلوبین) کاهش معنی داری داشت (p<0/05).نتیجه گیریوجود اختلاف معنی دار در افزایش مالون دی آلدئید و کاهش فعالیت آنزیم های آنتی اکسیدان بیماران دیابتی ممکن است در پیشرفت عوارض خطرناک در این بیماران نقش مهمی ایفا نماید. زیرا افزایش سطح مالون دی آلدئید و کاهش سیستم دفاعی آنتی اکسیدانی در بدن می تواند منجر به تخریب سلولی شود. به همین دلیل بیماران دیابتی ممکن است به آنتی اکسیدان های بیشتری نیاز داشته باشند. استفاده از مکمل های دارویی و غیر دارویی مهار کننده رادیکال های آزاد مانند ویتامین E، C و ترکیبات حاوی ویتامین C(مرکبات) نقش مهمی در تقویت سیستم دفاعی آنتی اکسیدانی داشته و می تواند در بهبود زندگی بیماران دیابتی بسیارمهم باشد.
کلید واژگان: پراکسیداسیون لیپید, سوپراکسید دسموتاز, دیابت نوع II, مالون دی آلدئید}Background and ObjectivesDiabetes mellitus may be associated with the imbalance between protective effect of antioxidants and increased free radical production with regard to discrepancies of the findings in previous researches the present study set out to determine the changes of plasma malondialdehyde and erythrocyte antioxidant superoxide dismutase activity in patients with type II diabetes mellitus.MethodsThis case-control study was conducted in 2005 using random sampling. 38 patients with type II diabetes mellitus who referred to 5th Azar diabetes center and 19 age and sex matched healthy controls were selected for this study. Heparinated blood samples were taken from the cases. The separated plasma was tested for blood sugar, lipid peroxidation and blood cells (for glycolisated Hb and superoxide dismutase enzyme activity). The collected data were analyzed by SPSS (ver. 10) using t-test.ResultsThe level of plasma malondialdehyde from type II diabetes mellitus patients (6.27±0.80 nmol/ml) was significantly different from that in control group (3.56±0.98 nmol/ml)(p<0.05). Erythrocyte superoxide dismutase activity from type II diabetes mellitus patients (678.78±59.36 U/gr Hb) was significantly lower than control group (1056.47±52.98 U/gr Hb) (p<0.05).ConclusionThe significant difference between the increase in malondialdehyde and decrease in the activity of antioxidant enzymes in patients with type II diabetes mellitus may predispose to the development of serious complications leading to cellular damage. This suggest that diabetic patients may need more antioxidants than normal. Supplementation with medical or non-medical free radical scavengers such as vitamins E and C or foods untaining vitamin C (sitrus fruits) have a potential role in reinforcing antioxidant defence and can be important in diabetic patients.Keywords: Lipid Peroxidation, Superoxide Dismutase, Type II Diabetes Mellitus}
- در این صفحه نام مورد نظر در اسامی نویسندگان مقالات جستجو میشود. ممکن است نتایج شامل مطالب نویسندگان هم نام و حتی در رشتههای مختلف باشد.
- همه مقالات ترجمه فارسی یا انگلیسی ندارند پس ممکن است مقالاتی باشند که نام نویسنده مورد نظر شما به صورت معادل فارسی یا انگلیسی آن درج شده باشد. در صفحه جستجوی پیشرفته میتوانید همزمان نام فارسی و انگلیسی نویسنده را درج نمایید.
- در صورتی که میخواهید جستجو را با شرایط متفاوت تکرار کنید به صفحه جستجوی پیشرفته مطالب نشریات مراجعه کنید.